Dow Down 1.27% Nasdaq Down 1.52%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
34.27 Up 0.39(1.15%) 3:44PM EDT - Nasdaq Real Time Price
Prev Close:33.88
Open:33.98
Bid:34.10 x 100
Ask:34.15 x 200
1y Target Est:42.32
Beta:1.8
Next Earnings Date:30-Oct-14ACOR Earnings announcement
Day's Range:33.52 - 34.57
52wk Range:27.51 - 39.95
Volume:636,957
Avg Vol (3m):655,144
Market Cap:1.41B
P/E (ttm):76.67
EPS (ttm):0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORUp 1.15%1.41B
BIIBDown 2.00%76.56B
TEVADown 1.49%45.20B

Key Statistics

Forward P/E (1 yr):74.15
P/S (ttm):3.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.21
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):3.59

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback